Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention

Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention

Lan Li,1 Zhenrong Ge,1 Dengke Zhang,1 Jun Kuang,2 Xiang Ma,3 Shubin Jiang1 1Coronary Care Unit, The Traditional Chinese Medicine Hospital, Xinjiang Medical University, 2Department of Cardiology, General Hospital of Xinjiang Military Command, 3Department of Cardiology, First Affiliated Hospital of X...

Full description

Bibliographic Details
Main Authors: Li L, Ge Z, Zhang D, Kuang J, Ma X, Jiang S
Format: Article
Language:English
Published: Dove Medical Press 2017-11-01
Series:Drug Design, Development and Therapy
Subjects:
low-dose tirofiban
non-ST-segment elevation acute coronary syndrome
quadruple drug therapy
Online Access:https://www.dovepress.com/efficacy-and-safety-of-quadruple-therapy-including-tirofiban-in-the-tr-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/efficacy-and-safety-of-quadruple-therapy-including-tirofiban-in-the-tr-peer-reviewed-article-DDDT

Similar Items